Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study
暂无分享,去创建一个
R. Thomas | G. Botti | G. D'aiuto | M. di Bonito | G. Comella | V. de Rosa | P. Comella | G. Frasci | M. Rubulotta | G. Iodice